# Five Prime Therapeutics, Inc. (FPRX)

Source: https://www.quantisnow.com/company/FPRX
Generated: 2026-11-10T15:53:41.198Z

- Ticker: FPRX
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Major Pharmaceuticals
- IPO year: 2013

## Latest FPRX news and filings

- 2022-01-04 13:00 UTC [Leadership Update] [Apexigen Announces Appointment of Francis Sarena as Chief Operating Officer](https://www.quantisnow.com/insight/apexigen-announces-appointment-of-francis-sarena-as-chief-operating-officer-2206314)
- 2021-05-17 20:34 UTC [SEC Form SC 13G/A filed by Five Prime Therapeutics, Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-five-prime-therapeutics-inc-752011)
- 2021-04-26 20:11 UTC [SEC Form 15-12B] [SEC Form 15-12B filed by Five Prime Therapeutics, Inc.](https://www.quantisnow.com/insight/sec-form-15-12b-filed-by-five-prime-therapeutics-inc-654283)
- 2021-04-22 04:15 UTC [SEC Form EFFECT filed by Five Prime Therapeutics, Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-five-prime-therapeutics-inc-641365)
- 2021-04-20 00:04 UTC [SEC Form 4] [SEC Form 4: Sarena Francis Willard received a gift of 2,385 units of Common Stock, was granted 66,000 units of Common Stock, disposed of $6,530,414 worth of Common Stock back to the company (171,853 units at $38.00)  and gifted 20,459 units of Common Stock, decreasing direct ownership by 100% to 0 units to satisfy withholding obligation](https://www.quantisnow.com/insight/sec-form-4-sarena-francis-willard-received-a-gift-of-630992)
- 2021-04-19 23:57 UTC [SEC Form 4] [SEC Form 4: Smith David V was granted 66,000 units of Common Stock and disposed of $5,279,986 worth of Common Stock back to the company (138,947 units at $38.00) , decreasing direct ownership by 100% to 0 units to satisfy tax liability](https://www.quantisnow.com/insight/sec-form-4-smith-david-v-was-granted-66000-units-630970)
- 2021-04-19 23:53 UTC [SEC Form 4] [SEC Form 4: Collins Helen Louise disposed of $5,150,786 worth of Common Stock back to the company (135,547 units at $38.00) , gifted 8,085 units of Common Stock and was granted 66,000 units of Common Stock, decreasing direct ownership by 100% to 0 units to satisfy tax liability](https://www.quantisnow.com/insight/sec-form-4-collins-helen-louise-disposed-of-5150786-worth-630964)
- 2021-04-19 23:49 UTC [SEC Form 4] [SEC Form 4: White David disposed of $1,270,074 worth of Common Stock back to the company (33,423 units at $38.00) , decreasing direct ownership by 100% to 0 units (tax withholding)](https://www.quantisnow.com/insight/sec-form-4-white-david-disposed-of-1270074-worth-of-630961)
- 2021-04-19 23:46 UTC [SEC Form 4] [SEC Form 4: RINGO WILLIAM R gifted 10,000 units of Common Stock, decreasing direct ownership by 100% to 0 units](https://www.quantisnow.com/insight/sec-form-4-ringo-william-r-gifted-10000-units-of-630959)
- 2021-04-19 23:42 UTC [SEC Form 4] [SEC Form 4: BERGER FRANKLIN M disposed of $190,000 worth of Common Stock back to the company (5,000 units at $38.00) , decreasing direct ownership by 100% to 0 units to satisfy tax liability](https://www.quantisnow.com/insight/sec-form-4-berger-franklin-m-disposed-of-190000-worth-630954)
- 2021-04-19 23:39 UTC [SEC Form 4] [SEC Form 4 filed by Dhingra Kapil](https://www.quantisnow.com/insight/sec-form-4-filed-by-dhingra-kapil-630952)
- 2021-04-19 23:35 UTC [SEC Form 4] [SEC Form 4 filed by Jensen Peder](https://www.quantisnow.com/insight/sec-form-4-filed-by-jensen-peder-630946)
- 2021-04-19 23:32 UTC [SEC Form 4] [SEC Form 4 filed by Nicholson Garry A](https://www.quantisnow.com/insight/sec-form-4-filed-by-nicholson-garry-a-630941)
- 2021-04-19 23:28 UTC [SEC Form 4] [SEC Form 4 filed by SCHAFER CAROL](https://www.quantisnow.com/insight/sec-form-4-filed-by-schafer-carol-630931)
- 2021-04-19 23:25 UTC [SEC Form 4] [SEC Form 4 filed by Lyons-Williams Lori](https://www.quantisnow.com/insight/sec-form-4-filed-by-lyons-williams-lori-630923)
- 2021-04-19 23:21 UTC [SEC Form 4] [SEC Form 4: Civik Thomas disposed of $2,620,898 worth of Common Stock back to the company (68,971 units at $38.00) , decreasing direct ownership by 100% to 0 units (tax withholding)](https://www.quantisnow.com/insight/sec-form-4-civik-thomas-disposed-of-2620898-worth-of-630913)
- 2021-04-16 20:09 UTC [SEC Form S-8 POS filed by Five Prime Therapeutics, Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-five-prime-therapeutics-inc-625421)
- 2021-04-16 20:11 UTC [SEC Form S-8 POS filed by Five Prime Therapeutics, Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-five-prime-therapeutics-inc-625405)
- 2021-04-16 20:09 UTC [SEC Form S-8 POS filed by Five Prime Therapeutics, Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-five-prime-therapeutics-inc-625402)
- 2021-04-16 20:07 UTC [SEC Form S-8 POS filed by Five Prime Therapeutics, Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-five-prime-therapeutics-inc-625346)
- 2021-04-16 20:07 UTC [SEC Form S-8 POS filed by Five Prime Therapeutics, Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-five-prime-therapeutics-inc-625345)
- 2021-04-16 20:05 UTC [SEC Form S-8 POS filed by Five Prime Therapeutics, Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-five-prime-therapeutics-inc-625321)
- 2021-04-16 20:03 UTC [SEC Form S-8 POS filed by Five Prime Therapeutics, Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-five-prime-therapeutics-inc-625314)
- 2021-04-16 20:05 UTC [SEC Form S-8 POS filed by Five Prime Therapeutics, Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-five-prime-therapeutics-inc-625297)
- 2021-04-16 20:01 UTC [SEC Form POS AM filed by Five Prime Therapeutics, Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-five-prime-therapeutics-inc-625263)
- 2021-04-16 12:25 UTC [Dividends] [Amgen Successfully Completes Acquisition Of Five Prime Therapeutics](https://www.quantisnow.com/insight/amgen-successfully-completes-acquisition-of-five-prime-therapeutics-624199)
- 2021-04-16 12:47 UTC [SEC Form 25-NSE filed by Five Prime Therapeutics, Inc.](https://www.quantisnow.com/insight/sec-form-25-nse-filed-by-five-prime-therapeutics-inc-623667)
- 2021-04-16 12:42 UTC [SEC Schedule 14D-9] [SEC Form SC 14D9/A filed by Five Prime Therapeutics, Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-14d9a-filed-by-five-prime-therapeutics-inc-623663)
- 2021-04-16 12:39 UTC [SEC Schedule TOT] [SEC Form SC TO-T/A filed by Five Prime Therapeutics, Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-to-ta-filed-by-five-prime-therapeutics-inc-623658)
- 2021-04-16 12:38 UTC [SEC Form 8-K] [Five Prime Therapeutics, Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Changes in Control of Registrant, Leadership Update, Financial Statements and Exhibits](https://www.quantisnow.com/insight/five-prime-therapeutics-inc-filed-sec-form-8-k-completion-of-623654)
- 2021-04-15 20:41 UTC [SEC Form 8-K] [Five Prime Therapeutics, Inc. filed SEC Form 8-K: Other Events](https://www.quantisnow.com/insight/five-prime-therapeutics-inc-filed-sec-form-8-k-other-events-622469)
- 2021-04-13 17:05 UTC [SEC Form 4] [SEC Form 4: Civik Thomas disposed of $420,679 worth of Common Stock (11,088 units at $37.94), decreasing direct ownership by 14% to 68,971 units](https://www.quantisnow.com/insight/sec-form-4-civik-thomas-disposed-of-420679-worth-of-613062)
- 2021-04-08 12:02 UTC [SEC Schedule TOT] [SEC Form SC TO-T/A filed by Five Prime Therapeutics, Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-to-ta-filed-by-five-prime-therapeutics-inc-599481)
- 2021-04-08 10:05 UTC [SEC Schedule 14D-9] [SEC Form SC 14D9/A filed by Five Prime Therapeutics, Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-14d9a-filed-by-five-prime-therapeutics-inc-598802)
- 2021-04-06 12:01 UTC [SEC Schedule TOT] [SEC Form SC TO-T/A filed by Five Prime Therapeutics, Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-to-ta-filed-by-five-prime-therapeutics-inc-589730)
- 2021-04-06 10:04 UTC [SEC Schedule 14D-9] [SEC Form SC 14D9/A filed by Five Prime Therapeutics, Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-14d9a-filed-by-five-prime-therapeutics-inc-588912)
- 2021-03-22 21:08 UTC [SEC Schedule TOT] [SEC Form SC TO-T/A filed by Five Prime Therapeutics, Inc.](https://www.quantisnow.com/insight/sec-form-sc-to-ta-filed-by-five-prime-therapeutics-inc-537050)
- 2021-03-22 20:39 UTC [SEC Schedule 14D-9] [SEC Form SC 14D9/A filed by Five Prime Therapeutics, Inc.](https://www.quantisnow.com/insight/sec-form-sc-14d9a-filed-by-five-prime-therapeutics-inc-536841)
- 2021-03-22 10:05 UTC [SEC Form 10-K filed by Five Prime Therapeutics, Inc.](https://www.quantisnow.com/insight/sec-form-10-k-filed-by-five-prime-therapeutics-inc-533968)
- 2021-03-18 12:08 UTC [SEC Schedule 14D-9] [SEC Form SC 14D9 filed by Five Prime Therapeutics, Inc.](https://www.quantisnow.com/insight/sec-form-sc-14d9-filed-by-five-prime-therapeutics-inc-525982)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/FPRX
- Earnings history: https://www.quantisnow.com/earnings/FPRX
- Dividend history: https://www.quantisnow.com/dividends/FPRX
- Insider transactions: https://www.quantisnow.com/insiders/FPRX
- Options chain: https://www.quantisnow.com/options/FPRX
- SEC 8-K filings only: https://www.quantisnow.com/company/FPRX/8-k
- RSS and alerts for FPRX: https://www.quantisnow.com/docs/rss-feeds.md